Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer

Journal of Intensive Care

Volumn 2, Issue 1, 2014, Pages

  Esper, Raúl C ^a   Estrada, Isis E D L M ^a   de la Torre León, Teresa ^a   Gutiérrez, Agustín O R ^a   López, Jorge A N ^a  

^a LIVER RESEARCH UNIT   (Mexico)

Author keywords

DAH (recombinant activated factor VII); Diffuse alveolar hemorrhage; Systemic lupus erythematosus (SLE)

Indexed keywords

C REACTIVE PROTEIN; DEFLAZACORT; METHYLPREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; ARTICLE; BLOOD GAS ANALYSIS; BRONCHOSCOPY; CASE REPORT; CHILL; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIVERTICULITIS; ECHOCARDIOGRAPHY; FEMALE; FEVER; FOLLOW UP; HEMOPTYSIS; HUMAN; HYPOCOMPLEMENTEMIA; HYPOXEMIA; JET MICRONEBULIZER; LAPAROSCOPIC SURGERY; LUNG GAS EXCHANGE; LUNG HEMORRHAGE; LUPUS ERYTHEMATOSUS; NEBULIZER; PRIORITY JOURNAL; PULSE OXIMETRY; SJOEGREN SYNDROME; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY;

EID: 84979195058     PISSN: None     EISSN: 20520492     Source Type: Journal    
DOI: 10.1186/s40560-014-0047-2     Document Type: Article

References (49)

1. Huaringa AJ, Leyva FJ, Giralt SA, Blanco J, Signes-Costa J, Velarde H. Outcome of bone marrow transplantation patients requiring mechanical ventilation. Crit Care Med 2006, 107:10-15.
2. Agusti C, Ramirez J, Picado C, Xaubet A, Carreras E, Ballester E. Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study. Crit Care Med 1995, 151:1006-1110.
3. Lewis ID, Defor T, Weisdorf DJ. Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy. Bone Marrow Transplant 2000, 26:539-543. 10.1038/sj.bmt.1702546, 11019844.
4. Levi M, Van Der Poll T, Cate H, Kuipers B, Biemond BJ, Jansen HM. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees. Am J Respir Crit Care Med 1998, 158:92-98. 10.1164/ajrccm.158.1.9709007, 9655712.
5. Huaringa AJ, Leyva FJ, Signes-Costa J, Morice RC, Raad I, Darwish AA. Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplantation patients. Bone Marrow Transplant 2000, 25:975-980. 10.1038/sj.bmt.1702335, 10800066.
6. Santiago CY, Vilá LM. Pulmonary hemorrhage in patients with systemic lupus erythematosus. Curr Respir Med Rev 2009, 5:49-54. 10.2174/157339809787354065.
7. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome. Am J Med 2004, 76:192-202.
8. Hunninghake GW, Fauci AS. Pulmonary involvement in the collagen vascular disease. Am Rev Respir Dis 1997, 119:471-503.
9. Emlen W. Systemic lupus erythematosus and mixed connective tissue disease. J Allergy Clin Immunol 1993, 13:291-311.
10. Tze-Yi SY. Diffuse alveolar hemorrhage. Am J Med 2007, 16:12-122.
11. Kamen DL, Strange C. Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 2010, 31:479-488. 10.1016/j.ccm.2010.05.001, 20692540.
12. Badsha H, The CL, Kong KO, Lian TY. Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 2003, 33:414-421. 10.1016/j.semarthrit.2003.09.006.
13. Abud MC, Diaz JE, Alarcon SD. Fatal pulmonary hemorrhage in systemic lupus erythematosus. J Rheumatol 1982, 12:558-561.
14. Byrd RB, Trunk G. Systemic lupus erythematosus presenting as pulmonary hemosiderosis. Chest 1976, 64:120-129.
15. Marino CT, Pertschuk LP. Pulmonary hemorrhage in systemic lupus erythematosus. Arch Intern Med 1981, 141:201-203. 10.1001/archinte.1981.00340020063018, 6970022.
16. Travis WD, Colby TV, Lombard C, Carpenter HA. Clinic pathologic studies of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990, 14:1112-1125. 10.1097/00000478-199012000-00003, 2252102.
17. Hughson MD, He ZJ, Henegar J, McMurray RR. Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus: immune complex small vascular injury with apoptosis. Arch Pathol Lab Med 2001, 125:475-483. 11260619.
18. Leatherman JW. Immune alveolar hemorrhage. Chest 1997, 91:891-897. 10.1378/chest.91.6.891.
19. Schwab EP, Schumacher HR, Freundlich B, Callegari PE. Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 1993, 23:8-15. 10.1016/S0049-0172(05)80022-8, 8235667.
20. Nellessen CM, Pöge U, Brensing KA, Sauerbruch T, Klehr HU. Diffuse alveolar hemorrhage in a systemic lupus erythematosus patient successfully treated with rituximab: a case report. Nephrol Dial Transplant 2008, 23:385-386. 10.1093/ndt/gfm701, 17933839.
21. Santos AS, Mandell BF, Fessler BJ. Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 2000, 118:1083-1090. 10.1378/chest.118.4.1083.
22. Koh WH, Thumboo J, Boey ML. Pulmonary haemorrhage in Oriental patients with systemic lupus erythematosus. Lupus 1997, 6:713-716. 10.1177/096120339700600906, 9412986.
23. Olson A, Schwarz M. Diffuse alveolar hemorrhage. Lupus 2007, 13:318-320.
24. Colby TV, Fukuoka J, Ewaskow SP, Helmers R, Leslie KO. Pathologic approach to pulmonary hemorrhage. Ann Diagn Pathol 2001, 5:309-319. 10.1053/adpa.2001.27923, 11598860.
25. Tze-Yi SY. Diffuse alveolar hemorrhage. Ann Diagn Pathol 2008, 17:94-105.
26. Raptis A, Mavroudis D, Suffredini A, Molldrem J, Rhee FV, Childs R. High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients. Bone Marrow Transplant 1999, 24:879-883. 10.1038/sj.bmt.1701995, 10516700.
27. Speck U. Diffuse alveolar hemorrhage syndromes. Curr Opin Reumatol 2001, 13:12-17. 10.1097/00002281-200101000-00003.
28. Mendoza AC, Moreno R, Cuevas E, Borja A. Treating severe systemic lupus erythematosus with rituximab. Reumatol Clin 2009, 5:147-152. 10.1016/j.reuma.2008.09.008.
29. Hedner U. Recombinant factor VIIa (NovoSeven) as a hemostatic agent. Dis Mon 2003, 49:39-48. 12525827.
30. Pastores SM, Papadopoulos E, Voigt L, Halpern NA. Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa. Chest 2003, 124:2400-2403. 10.1378/chest.124.6.2400, 14665531.
31. Hicks K, Peng D, Gajewski JL. Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa. Bone Marrow Transplant 2002, 30:975-978. 10.1038/sj.bmt.1703731, 12476294.
32. Henke D, Falk RJ, Gabriel DA. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med 2004, 140:493-494. 10.7326/0003-4819-140-6-200403160-00033, 15023729.
33. Sabharwal AK, Bajaj SP, Ameri A, Tricomi SM, Hyers TM, Dahms TE. Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med 1995, 151:758-767. 10.1164/ajrccm/151.3_Pt_1.758, 7881667.
34. Heslet L, Nielsen JD, Levi M. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care 2006, 10:1-6. 10.1186/cc5132.
35. Carrillo ER, Elizondo AS, Sánchez ZJ, Carrillo CJ. Hemorragia alveolar secundaria a lupus eritematoso generalizado, tratada con factor VII recombinante activado. informe de un caso y revisión de la literatura. [Alveolar hemorrhage secondary to lupus erythematosus treated with recombinant activated factor VII. Report of a case and review of the literature.]. Gac Med Mex 2007, 143:83-86.
36. Grochova M, Kalnasova B, Firment J, Olejarova I, Roland R, Lazurova I. Pulmonary administration of activated recombinant factor VII. Bratisl Lek Listy 2011, 112:29-33. 21452776.
37. Dabar G, Harmouche C, Jammal M. Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage. Rev Mal Respir 2011, 28:106-111. 10.1016/j.rmr.2010.07.007, 21277485.
38. Estella A, Jareño A, Perez-Bello FL. Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories. Cases J 2008, 12:150-152. 10.1186/1757-1626-1-150.
39. Enomoto M, Thorborg P. Emerging off-label uses for recombinant activated factor VII: grading the evidence. Crit Care Clin 2005, 21:611-632. 10.1016/j.ccc.2005.04.001, 15992675.
40. Hoffman M, Monroe MD. The action of high-dose factor VIIa in a cell-based model hemostasis. Dis Mon 2003, 49:1-7. 10.1053/shem.2001.29504.
41. Veldman A, Hoffman M, Ehrenforth S. New insights into the coagulation system and implication for new therapeutic options with recombinant factor VIIa. Curr Med Chem 2003, 10:797-811. 10.2174/0929867033457728, 12678684.
42. Chang SJ, Yen YS, Huo AP, Lee SS, Huang DF. Acute massive pulmonary hemorrhage after craniotomy in a patient with systemic lupus erythematosus. Mikrobiol Zh 2005, 8:69-72.
43. Quintana DM, Sánchez CM, García LA. Factor VII activado recombinante [Recombinant activated factor VII]. Med Intensiva 2007, 31:326-330. 10.1016/S0210-5691(07)74831-3.
44. Macdonald JA, Fraser JF, Foot CL, Khoa T. Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia. Chest 2006, 130:577-579. 10.1378/chest.130.2.577, 16899862.
45. Girolami B. Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review. Haemophilia 2006, 12:345-351. 10.1111/j.1365-2516.2006.01299.x, 16834733.
46. Mayer S. Recombinant activated factor VII for acute intracerebral hemorrhage. NEJM 2005, 352:777-785. 10.1056/NEJMoa042991, 15728810.
47. Mayer S. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. NEJM 2008, 358:2127-2137. 10.1056/NEJMoa0707534, 18480205.
48. Thomas R. Thromboembolic complications associated with factor VIIa administration. J Trauma 2007, 62:564-569. 10.1097/TA.0b013e318031afc2, 17414329.
49. Hardy JF. Efficacy and safety of recombinant activated factor VII to control bleeding in nonhemophiliac patients: a review of 17 randomized controlled trials. Ann Thorac Surg 2008, 86:1038-1048. 10.1016/j.athoracsur.2008.05.013, 18721620.